Effects of Psychotropic Drugs on Seizure Threshold during Electroconvulsive Therapy

키워드

참고문헌 (74)

1. Bersani G, "Seizure threshold variations in ECT-treated chronic patients with schizophrenia : a brief report", Riv Psichiatr, 49, pp.84~88 (2014)
2. Galvez V, "Predictors of seizure threshold in right unilateral ultrabrief electroconvulsive therapy : role of concomitant medications and anaesthesia used", Brain Stimul, 8, pp.486~492 (2015)
3. van Waarde JA, "Clinical predictors of seizure threshold in electroconvulsive therapy : a prospective study", Eur Arch Psychiatry Clin Neurosci, 263, pp.167~175 (2013)
4. Duthie AC, "Anticonvulsant mechanisms of electroconvulsive therapy and relation to therapeutic efficacy", J ECT, 31, pp.173~178 (2015)
5. Maletzky BM, "Seizure duration and clinical effect in electroconvulsive therapy", Compr Psychiatry, 19, pp.541~550 (1978)
6. Sackeim HA, "Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy", N Engl J Med, 328, pp.839~846 (1993)
7. Enns M, "Electrical dose titration for electroconvulsive therapy : a comparison with dose prediction methods", Convuls Ther, 11, pp.86~93 (1995)
8. Royal College of Psychiatrists, "The ECT handbook: The Second Report of the Royal College of Psychiatrists’ Special Committee on ECT" (1995), Royal College of Psychiatrists
9. Abrams R, "Stimulus titration and ECT dosing", J ECT, 18, pp.3~9 (2002)
10. Petrides G, "Seizure threshold in a large sample : implications for stimulus dosing strategies in bilateral electroconvulsive therapy : a report from CORE", J ECT, 25, pp.232~237 (2009)
11. Yasuda K, "Seizure threshold and the half-age method in bilateral electroconvulsive therapy in Japanese patients", Psychiatry Clin Neurosci, 69, pp.49~54 (2015)
12. Datto C, "Augmentation of seizure induction in electroconvulsive therapy : a clinical reappraisal", J ECT, 18, pp.118~125 (2002)
13. Deng ZD, "Controlling stimulation strength and focality in electroconvulsive therapy via current amplitude and electrode size and spacing", J ECT, 29, pp.325~ (2013)
14. Chanpattana W, "Seizure threshold rise during electroconvulsive therapy in schizophrenic patients", Psychiatry Res, 96, pp.31~40 (2000)
15. Hedges D, "Antipsychotic medication and seizures : a review", Drugs Today(Barc), 39, pp.551~557 (2003)
16. Nitturkar AR, "Effect of age and anticonvulsants on seizure threshold during bilateral electroconvulsive therapy with brief-pulse stimulus : a chart-based analysis", Indian J Psychiatry, 58, pp.190~197 (2016)
17. Pisani F, "Effects of psychotropic drugs on seizure threshold", Drug Saf, 25, pp.91~110 (2002)
18. Herz MI, "Practice guideline for the treatment of patients with schizophrenia", Am J Psychiatry, 154, pp.1~63 (1997)
19. Woods SW, "Chlorpromazine equivalent doses for the newer atypical antipsychotics", J Clin Psychiatry, 64, pp.663~667 (2003)
20. Hayasaka Y, "Dose equivalents of antidepressants : evidence-based recommendations from randomized controlled trials", J Affect Disord, 180, pp.179~184 (2015)
21. Ogren SO, "Effects of dopamine-D(1)and dopamine-D(2)receptor agonists and antagonists on seizures induced by chemoconvulsants in mice", Pharmacol Toxicol, 72, pp.213~220 (1993)
22. Okazaki M, "Do antipsychotic drugs increase seizure frequency in epilepsy patients?", Eur Neuropsychopharmacol, 24, pp.1738~1744 (2014)
23. Torta R, "Atypical antipsychotics and serotoninergic antidepressants in patients with epilepsy: pharmacodynamic considerations", Epilepsia, 43(Suppl 2), pp.8~13 (2002)
24. Devinsky O, "Clozapine-related seizures", Neurology, 41, pp.369~371 (1991)
25. Pacia SV, "Clozapine-related seizures-experience with 5,629 patients", Neurology, 44, pp.2247~2249 (1994)
26. Taner E, "Clozapine related seizures: prevalence and characteristic features", Int J Neuropsychopharmacology, 9, pp.S277~S277 (2006)
27. Moezi L, "The effects of sub-chronic treatment with aripiprazole on pentylenetetrazole-and electroshock-induced seizures in mice : the role of nitric oxide", Pharmacology, 95, pp.264~270 (2015)
28. Burke K, "Seizure Promotion and Protection by D-1 and D-2 Dopaminergic Drugs in the Mouse", Pharmacol Biochem Behav, 36, pp.729~733 (1990)
29. al-Tajir G, "Opposite Effects of Stimulation of D1 and D2 Dopamine-Receptors on the Expression of Motor Seizures in Mouse and Rat", Neuropharmacology, 29, pp.657~661 (1990)
30. al-Tajir G, "Proconvulsant Effect of Skf-38393 Mediated by Nigral D1 Receptors", Eur J Pharmacol, 182, pp.245~251 (1990)
31. Starr MS, "Seizure promotion by D(1)agonists does not correlate with other dopaminergic properties", J Neural Transm Park Dis Dement Sect, 6, pp.27~34 (1993)
32. Yokoyama H, "MK-801 and dopaminergic system in electrically-induced convulsions in mice", Yakubutsu Seishin Kodo, 13, pp.309~313 (1993)
33. Frey HH, "Influence of inhibitors of the high affinity GABA uptake on seizure thresholds in mice", Neuropharmacology, 18, pp.581~590 (1979)
34. Krogsgaard-Larsen P, "GABA uptake inhibitors : relevance to antiepileptic drug research", Epilepsy Res, 1, pp.77~93 (1987)
35. Sanacora G, "Increased cortical GABA concentrations in depressed patients receiving ECT", Am J Psychiatry, 160, pp.577~579 (2003)
36. Farnbach-Pralong D, "Clozapine and olanzapine treatment decreases rat cortical and limbic GABA(A) receptors", Eur J Pharmacol, 349, pp.R7~R8 (1998)
37. Nazari-Serenjeh F, "Functional correlation between gabaergic and dopaminergic systems of dorsal hippocampus and ventral tegmental area in passive avoidance learning in rats", Neuroscience, 196, pp.104~114 (2011)
38. Mrzljak L, "Localization of dopamine D4 receptors in GABAergic neurons of the primate brain", Nature, 381, pp.245~248 (1996)
39. Seamans JK, "Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons", J Neurosci, 21, pp.3628~3638 (2001)
40. Floran B, "Activation of D1 dopamine-receptors stimulates the release of gaba in the basal ganglia of the rat", Neurosci Lett, 116, pp.136~140 (1990)
41. Reubi JC, "Dopamine selectively increases H-3-Gaba release from slices of rat substantia nigra invitro", Nature, 268, pp.652~654 (1977)
42. Bernath S, "Dopamine may influence striatal gaba release via 3 separate mechanisms", Brain Res, 476, pp.373~376 (1989)
43. Mula M, "Use of psychotropic drugs in patients with epilepsy : interactions and seizure risk", Exp Rev Neurother, 4, pp.953~964 (2004)
44. Koch-Stoecker S., "Antipsychotic drugs and epilepsy: indications and treatment guidelines", Epilepsia, 43(suppl 2), pp.19~24 (2002)
45. Centorrino F, "EEG abnormalities during treatment with typical and atypical Antipsychotics", Am J Psychiatry, 159, pp.109~115 (2002)
46. Moller HJ, "Antipsychotic and antidepressive effects of second generation antipsychotics-two different pharmacological mechanisms?", Eur Arch Psychiatry Clin Neurosci, 255, pp.190~201 (2005)
47. Yang Y, "The dilemma of treatments for epileptic patients with depression", Int J Neurosci, 125, pp.566~577 (2015)
48. Montgomery SA, "Antidepressants and seizures : emphasis on newer agents and clinical implications", Int J Clin Pract, 59, pp.1435~1440 (2005)
49. Citraro R, "Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG", Rij rat model of absence epilepsy, 2015, pp.172, 3177~3188
50. Lloyd KG, "GABA synapses, depression, and antidepressant drugs", Psychopharmacol Ser, 3, pp.113~126 (1987)
51. Shiah IS, "GABA function in mood disorders : an update and critical review", Life Sci, 63, pp.1289~1303 (1998)
52. Ropert N, "Serotonin facilitates GABAergic transmission in the CA1 region of rat hippocampus in vitro", J Physiol, 441, pp.121~136 (1991)
53. McCormick DA, "Serotonin and noradrenaline excite GABAergic neurones of the guinea-pig and cat nucleus reticularis thalami", J Physiol, 442, pp.235~255 (1991)
54. Ciranna L, "Serotonin as a modulator of glutamate-and GABA-mediated neurotransmission : implications in physiological functions and in pathology", Curr Neuropharmacol, 4, pp.101~114 (2006)
55. Filakovszky J, "A serotonin-1A receptor agonist and an N-methyl-D-aspartate receptor antagonist oppose each others effects in a genetic rat epilepsy model", Neurosci Lett, 261, pp.89~92 (1999)
56. Bagdy G, "Serotonin and epilepsy", J Neurochem, 100, pp.857~873 (2007)
57. Bhagwagar Z, "Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor", Am J Psychiatry, 161, pp.368~370 (2004)
58. Bowers G, "Region-specific regulation of glutamic acid decarboxylase(GAD)mRNA expression in central stress circuits", J Neurosci, 18, pp.5938~5947 (1998)
59. Herman JP, "Norepinephrine-gamma-aminobutyric acid(GABA)interaction in limbic stress circuits : effects of reboxetine on GABAergic neurons", Biol Psychiatry, 53, pp.166~174 (2003)
60. Beverly JL, "Norepinephrine mediates glucoprivic-induced increase in GABA in the ventromedial hypothalamus of rats", Am J Physiol Regul Integr Comp Physiol, 279, pp.R990~R996 (2000)
61. Segal M, "The action of norepinephrine in the rat hippocampus. II. Activation of the input pathway", Brain Res, 72, pp.99~114 (1974)
62. Szot P, "Norepinephrine-deficient mice have increased susceptibility to seizure-inducing stimuli", J Neurosci, 19, pp.10985~10992 (1999)
63. Dailey JW, "Indices of noradrenergic function in the central nervous system of seizure-naive genetically epilepsy-prone rats", Epilepsia, 27, pp.665~670 (1986)
64. Browning RA, "Regional brain abnormalities in norepinephrine uptake and dopamine beta-hydroxylase activity in the genetically epilepsy-prone rat", J Pharmacol Exp Ther, 249, pp.229~235 (1989)
65. Giorgi FS, "The role of norepinephrine in epilepsy : from the bench to the bedside", Neurosci Biobehav Rev, 28, pp.507~524 (2004)
66. Bough KJ, "Anticonvulsant mechanisms of the ketogenic diet", Epilepsia, 48, pp.43~58 (2007)
67. Leke R, "Synthesis of neurotransmitter GABA via the neuronal tricarboxylic acid cycle is elevated in rats with liver cirrhosis consistent with a high GABAergic tone in chronic hepatic encephalopathy", J Neurochem, 117, pp.824~832 (2011)
68. Kopeloff LM, "Serum cholesterol in monkeys with chronic epileptic foci", Life Sci I, 10, pp.869~876 (1971)
69. McClintock SM, "Multifactorial determinants of the neurocognitive effects of electroconvulsive therapy", J ECT, 30, pp.165~176 (2014)
70. Haskett RF, "Adjunctive psychotropic medications during electroconvulsive therapy in the treatment of depression, mania, and schizophrenia", J ECT, 26, pp.196~201 (2010)
71. Sackeim HA, "Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes : short-term efficacy and adverse effects", Arch Gen Psychiatry, 66, pp.729~737 (2009)
72. Kristensen D, "Antipsychotic polypharmacy in a treatment-refractory schizophrenia population receiving adjunctive treatment with electroconvulsive therapy", J ECT, 29, pp.271~276 (2013)
73. Fink M, "ECT and drugs : concurrent Administration", Convuls Ther, 9, pp.237~240 (1993)
74. Ishihara K, "Mechanism underlying the therapeutic effects of electroconvulsive therapy(ECT)on depression", Jpn J Pharmacol, 80, pp.185~189 (1999)

관련 논문AI추천